Physician profile
Ryan M Danowski
NPI 1871880831
$3,726.89
in general payments reported to CMS, 2019-2025
19 companies · $1,313 in 2025
The $1,313 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $28.43 · 2021: $166 · 2022: $314 · 2023: $160 · 2024: $767 · 2025: $1,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,177 · Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,176.82 |
| Food and Beverage | $1,062.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eclipse Technology Solutions INC. | $885.92 | 2024-2025 | |
| Stryker Corporation | $568.93 | 2019-2024 | Restoration, Insignia, Accolade |
| Arthrex, INC. | $482.45 | 2025 | |
| Depuy Synthes Sales INC. | $433.61 | 2019-2024 | Na |
| Liberty Surgical INC. | $427.00 | 2019 | |
| Skeletal Dynamics INC | $227.01 | 2024 | Geminus, Ijs, Implate |
| Tenex Health INC. | $121.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $119.96 | 2023 | Explor |
| Ethicon US, LLC | $119.47 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.93 | 2024 | Relistor |
| Smith+Nephew, INC. | $73.42 | 2020-2022 | |
| Merz Pharmaceuticals, LLC | $57.56 | 2023-2024 | Xeomin |
| Si-Bone, INC. | $35.08 | 2024 | |
| Medtronic, INC. | $19.35 | 2024 | Intellis Adaptivestim |
| Otsuka America Pharmaceutical, INC. | $18.41 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $13.77 | 2022 | |
| Solventum Corporation | $13.63 | 2024 | Prevena |
| Hikma Pharmaceuticals USA | $13.23 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Danowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.